These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18309981)

  • 21. World Health Organization fact sheet. Tuberculosis.
    World Health Organization
    Saudi Med J; 2004 Aug; 25(8):1136-8. PubMed ID: 15457607
    [No Abstract]   [Full Text] [Related]  

  • 22. Tuberculosis--fighting a losing battle?
    Tan KK
    Singapore Med J; 1995 Apr; 36(2):209-11. PubMed ID: 7676270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Shortened, strictly supervised tuberculosis treatment in populations with moderate drug resistance levels: international impact perspective].
    Santos-Preciado JI; Franco-Paredes C
    Rev Invest Clin; 2005; 57(3):488-90. PubMed ID: 16187710
    [No Abstract]   [Full Text] [Related]  

  • 24. [How to use rifamycin rationally: the key issue to prevent multidrug-resistant tuberculosis].
    Sha W
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Oct; 37(10):733-6. PubMed ID: 25537407
    [No Abstract]   [Full Text] [Related]  

  • 25. New World Health Organization Treatment Recommendations for Multidrug-Resistant Tuberculosis: Are We Well Enough Prepared?
    Kranzer K; Kalsdorf B; Heyckendorf J; Andres S; Merker M; Hofmann-Thiel S; Bloemberg GV; Hoffmann H; Niemann S; Lange C; Maurer FP
    Am J Respir Crit Care Med; 2019 Aug; 200(4):514-515. PubMed ID: 31026398
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug-resistance--a challenge for tuberculosis control in the European Union and European Economic Area.
    van der Werf MJ; Sprenger M
    Euro Surveill; 2014 Mar; 19(11):. PubMed ID: 24679718
    [No Abstract]   [Full Text] [Related]  

  • 27. Eligibility for the Shorter Multidrug-Resistant Tuberculosis Regimen: Ambiguities in the World Health Organization Recommendations.
    Varaine F; Guglielmetti L; Huerga H; Bonnet M; Kiria N; Sitienei JK; Rich M; Mitnick CD
    Am J Respir Crit Care Med; 2016 Oct; 194(8):1028-1029. PubMed ID: 27739887
    [No Abstract]   [Full Text] [Related]  

  • 28. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries.
    Espinal MA; Kim SJ; Suarez PG; Kam KM; Khomenko AG; Migliori GB; Baéz J; Kochi A; Dye C; Raviglione MC
    JAMA; 2000 May; 283(19):2537-45. PubMed ID: 10815117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preventive therapy for multidrug-resistant tuberculosis.
    Kirkland LR
    JAMA; 1996 Jul; 276(1):27-8. PubMed ID: 8667529
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug resistance and tuberculosis elimination in low-incidence countries.
    Falzon D; Zellweger JP; Migliori GB; Jaramillo E
    Eur Respir J; 2014 Dec; 44(6):1408-11. PubMed ID: 25435527
    [No Abstract]   [Full Text] [Related]  

  • 31. New tools for achieving tuberculosis control: progress and reflexion.
    Zumla A; Yew WW
    Int J Tuberc Lung Dis; 2011 Mar; 15(3):285-6. PubMed ID: 21333093
    [No Abstract]   [Full Text] [Related]  

  • 32. Improving technical assistance for drug-resistant tuberculosis.
    Furin J
    Int J Tuberc Lung Dis; 2011 Mar; 15(3):421-2. PubMed ID: 21333116
    [No Abstract]   [Full Text] [Related]  

  • 33. Scaling up programmatic management of drug-resistant tuberculosis: a prioritized research agenda.
    Cobelens FG; Heldal E; Kimerling ME; Mitnick CD; Podewils LJ; Ramachandran R; Rieder HL; Weyer K; Zignol M;
    PLoS Med; 2008 Jul; 5(7):e150. PubMed ID: 18613746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Programmatic management of multidrug resistant TB.
    Sarin R
    Indian J Tuberc; 2009 Oct; 56(4):171-3. PubMed ID: 20469727
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy and safety of regimens for drug-resistant tuberculosis.
    Yates TA; Nunn AJ
    Lancet Infect Dis; 2016 Nov; 16(11):1218-1219. PubMed ID: 27788973
    [No Abstract]   [Full Text] [Related]  

  • 36. Totally drug-resistant tuberculosis in India: who let the djinn out?
    Udwadia ZF
    Respirology; 2012 Jul; 17(5):741-2. PubMed ID: 22564108
    [No Abstract]   [Full Text] [Related]  

  • 37. Management of contacts of multidrug-resistant tuberculosis patients in the European Union and European Economic Area.
    van der Werf MJ; Sandgren A; Manissero D
    Int J Tuberc Lung Dis; 2012; 16(3):426. PubMed ID: 22640458
    [No Abstract]   [Full Text] [Related]  

  • 38. Multidrug-resistant tuberculosis in the USA: the end of the beginning.
    Nolan CM
    Tuber Lung Dis; 1996 Aug; 77(4):293-4. PubMed ID: 8796241
    [No Abstract]   [Full Text] [Related]  

  • 39. What is new in the WHO consolidated guidelines on drug-resistant tuberculosis treatment?
    Sharma SK; Dheda K
    Indian J Med Res; 2019 Mar; 149(3):309-312. PubMed ID: 31249191
    [No Abstract]   [Full Text] [Related]  

  • 40. [Interpretation of WHO consolidated guidelines on tuberculosis module 4: drug resistant tuberculosis treatment].
    Zhang LJ; Liu YH; Gao JT; Chen Z; Li L
    Zhonghua Jie He He Hu Xi Za Zhi; 2021 Apr; 44(4):349-353. PubMed ID: 33832022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.